76 related articles for article (PubMed ID: 16810301)
1. Histone deacetylase inhibitors induce apoptosis with minimal viral reactivation in cells infected with Kaposi's sarcoma-associated herpesvirus.
Niedermeier A; Talanin N; Chung EJ; Sells RE; Borris DL; Orenstein JM; Trepel JB; Blauvelt A
J Invest Dermatol; 2006 Nov; 126(11):2516-24. PubMed ID: 16810301
[TBL] [Abstract][Full Text] [Related]
2. Suberoyl bis-hydroxamic acid reactivates Kaposi's sarcoma-associated herpesvirus through histone acetylation and induces apoptosis in lymphoma cells.
Iida S; Mine S; Ueda K; Suzuki T; Hasegawa H; Katano H
J Virol; 2021 Mar; 95(5):. PubMed ID: 33328303
[TBL] [Abstract][Full Text] [Related]
3. SUMO Modification of Histone Demethylase KDM4A in Kaposi's Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Yeh WW; Chen YQ; Yang WS; Hong YC; Kao S; Liu TT; Chen TW; Chang L; Chang PC
J Virol; 2022 Aug; 96(16):e0075522. PubMed ID: 35914074
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
[TBL] [Abstract][Full Text] [Related]
5. Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines.
Zoeteweij JP; Rinderknecht AS; Davis DA; Yarchoan R; Blauvelt A
J Med Virol; 2002 Mar; 66(3):378-83. PubMed ID: 11793390
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation.
Shin HJ; DeCotiis J; Giron M; Palmeri D; Lukac DM
J Virol; 2014 Jan; 88(2):1281-92. PubMed ID: 24227836
[TBL] [Abstract][Full Text] [Related]
8. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
Cho HJ; Yu F; Sun R; Lee D; Song MJ
Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
[TBL] [Abstract][Full Text] [Related]
9. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells.
Li X; Feng J; Sun R
J Virol; 2011 Jan; 85(2):715-24. PubMed ID: 21068240
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Kedes DH; Ganem D
J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy.
Andrei G; Snoeck R
Curr Opin Infect Dis; 2015 Dec; 28(6):611-24. PubMed ID: 26524334
[TBL] [Abstract][Full Text] [Related]
13. Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus.
Cinquina CC; Grogan E; Sun R; Lin SF; Beardsley GP; Miller G
Virology; 2000 Mar; 268(1):201-17. PubMed ID: 10683342
[TBL] [Abstract][Full Text] [Related]
14. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.
Li X; Chen S; Sun R
J Virol; 2012 Jun; 86(12):6668-76. PubMed ID: 22496227
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus.
Zoeteweij JP; Moses AV; Rinderknecht AS; Davis DA; Overwijk WW; Yarchoan R; Orenstein JM; Blauvelt A
Blood; 2001 Apr; 97(8):2374-80. PubMed ID: 11290600
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication.
Chang J; Renne R; Dittmer D; Ganem D
Virology; 2000 Jan; 266(1):17-25. PubMed ID: 10612656
[TBL] [Abstract][Full Text] [Related]
17. Hesperetin inhibits KSHV reactivation and is reversed by HIF1α overexpression.
Long WY; Zhao GH; Wu Y
J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34747688
[TBL] [Abstract][Full Text] [Related]
18. Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus.
Kati S; Hage E; Mynarek M; Ganzenmueller T; Indenbirken D; Grundhoff A; Schulz TF
J Virol Methods; 2015 Jun; 217():79-86. PubMed ID: 25736227
[TBL] [Abstract][Full Text] [Related]
19. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Medveczky MM; Horvath E; Lund T; Medveczky PG
AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
Zhang X; Wang JF; Kunos G; Groopman JE
Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
